WINT: Windtree Therapeutics, Inc. Stock

by  •  • Comments Off on WINT: Windtree Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 0.17
Enterprise Value ($M) -0.46
Book Value ($M) 10.29
Book Value / Share 2.89
Price / Book 0.02
NCAV ($M) -14.88
NCAV / Share -4.19
Price / NCAV -0.01

Profitability (mra)
Return on Invested Capital (ROIC) -1.35
Return on Assets (ROA) -0.53
Return on Equity (ROE) -1.04

Liquidity (mrq)
Quick Ratio 0.25
Current Ratio 0.25

Balance Sheet (mrq) ($M)
Current Assets 1.59
Assets 26.77
Liabilities 16.48
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -25.02
Net Income -1.79
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -15.40
Cash from Investing -0.01
Cash from Financing 12.73

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 2.55 6.87
11-14 13G/A Flynn James E 0.00 -100.00
11-14 13G/A Lind Global Fund II LP 0.40 -94.44

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-04 161,600 489,185 33.03
2025-06-03 79,933 200,510 39.86
2025-06-02 101,091 238,155 42.45
2025-05-30 36,815 110,853 33.21

(click for more detail)

Similar Companies
VXRT – Vaxart, Inc. VYNE – VYNE Therapeutics Inc.
WHWK – Whitehawk Therapeutics, Inc. XBIO – Xenetic Biosciences, Inc.
XCUR – Exicure, Inc.


Financial data and stock pages provided by
Fintel.io